Study
Commercial ProductionHigh ImpactStrong effect

Dual-detector GC-MS/FID enhances metabolite quantification in human serum by over 3.7x

Integrating a Flame Ionization Detector (FID) in parallel with a high-resolution Gas Chromatography-Orbitrap Mass Spectrometer (GC-Orbitrap-MS) significantly expands the number of quantifiable metabolites in human serum compared to using MS alone.

bioRxiv (Cold Spring Harbor Laboratory) · 2019

01

Key Findings

  • 01GC-Orbitrap-MS (EI mode) quantified 294 metabolites across 89 biological pathways.
  • 02Parallel GC-FID analysis quantified 1117 peaks.
  • 03Representative peaks from FID and MS showed good correspondence in relative abundance.
  • 04The combined approach offers robust and orthogonal quantification.
02

Application

Design takeaway

For complex sample analysis in metabolomics, consider integrating multiple detection techniques (e.g., MS and FID) to achieve a more comprehensive and robust dataset.

How to apply

When designing analytical workflows for complex biological samples, evaluate the potential benefits of coupling different detector types to a single chromatographic separation.

Project actions

  • 01When selecting analytical equipment for a design project, consider the trade-offs between single-detector simplicity and multi-detector comprehensiveness.
  • 02Think about how different detection methods can complement each other to provide a more complete picture of a sample's composition.
03

Method & Evidence

AimTo evaluate the benefits of combining GC-Orbitrap-MS with an in-line FID for enhanced metabolite identification and quantification in human serum.
MethodComparative analytical study
ProcedureHuman serum samples were analyzed using a GC-Orbitrap-MS platform equipped with both Electron Ionization (EI) for mass spectrometry and an in-line FID. The study compared the number of identified metabolites and their relative abundances between the GC-Orbitrap-MS (EI mode) and the parallel GC-FID analysis.
ContextClinical metabolomics research, analytical chemistry

Variables

IVDetector type (GC-Orbitrap-MS vs. GC-FID vs. combined)
DVNumber of quantifiable metabolites/peaks, relative abundance of metabolites
CVSample type (human serum), chromatographic conditions, ionization mode (EI for MS)
04

Strengths & Limitations

Strengths

  • +Utilizes a high-resolution mass spectrometer for accurate mass measurements.
  • +Employs an orthogonal detection method (FID) to capture a broader range of compounds.

Limitations

The cost and complexity of operating dual-detector systems can be a significant limitation for smaller research groups or resource-constrained projects.

Reliability & validity

The study's validity is supported by the use of a high-resolution instrument and the comparison of relative abundances between detectors. Reliability would be enhanced by repeating analyses on multiple serum samples and ensuring consistent instrument calibration.

Think critically

What are the potential downstream impacts on research conclusions if a less comprehensive analytical method (e.g., MS alone) is used when a dual-detector approach could have provided more data?

05

Design Principles

"Orthogonal detection methods enhance analytical coverage and confidence in complex sample analysis."

This dual-detector approach offers a more comprehensive analytical capability for complex biological samples, crucial for advancing clinical metabolomics research. It allows for more robust identification and quantification of a wider range of metabolites, leading to deeper insights into disease biomarkers and metabolic pathways.

06

What This Means for Your Design

Using two different types of detectors (one that measures mass and one that measures general organic compounds) at the same time when analyzing a sample can help you find and measure many more different substances in that sample.

How to use in your project

  • 1.Reference this study when discussing the selection of analytical techniques for complex sample analysis, particularly in the context of improving data yield and confidence in identification.
07

Add to My Project

08

Quick Cite

(2019). Comparison of a GC-Orbitrap-MS with Parallel GC-FID Capabilities for Metabolomics of Human Serum. bioRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.1101/740795 Retrieved from https://designdex.org/study/7f847f2e-0558-4066-af34-2d145ef296a8/dual-detector-gc-ms-fid-enhances-metabolite-quantification-in-human-serum-by-over-3-7x

Paragraph starter

The integration of orthogonal detection methods, such as combining Gas Chromatography-Mass Spectrometry (GC-MS) with Flame Ionization Detection (GC-FID), has been shown to significantly enhance the analytical coverage of complex samples. For instance, a study on human serum metabolomics demonstrated that a parallel GC-FID setup alongside a GC-Orbitrap-MS identified over 3.7 times more quantifiable signals, offering a more comprehensive understanding of the sample's chemical composition and improving the robustness of metabolite quantification.

09

Source

bioRxiv (Cold Spring Harbor Laboratory)

Comparison of a GC-Orbitrap-MS with Parallel GC-FID Capabilities for Metabolomics of Human Serum

journal · 2019

View source

Questions about this research

What does the research say about dual-detector gc-ms/fid enhances metabolite quantification in human serum by over 3.7x?
For complex sample analysis in metabolomics, consider integrating multiple detection techniques (e.g., MS and FID) to achieve a more comprehensive and robust dataset. Evidence: bioRxiv (Cold Spring Harbor Laboratory) (2019).
Why does "Dual-detector GC-MS/FID enhances metabolite quantification in human serum by over 3.7x" matter for design?
This dual-detector approach offers a more comprehensive analytical capability for complex biological samples, crucial for advancing clinical metabolomics research. It allows for more robust identification and quantification of a wider range of metabolites, leading to deeper insights into disease biomarkers and metabolic pathways.
How can designers apply this research?
For complex sample analysis in metabolomics, consider integrating multiple detection techniques (e.g., MS and FID) to achieve a more comprehensive and robust dataset.
What were the main findings?
GC-Orbitrap-MS (EI mode) quantified 294 metabolites across 89 biological pathways.. Parallel GC-FID analysis quantified 1117 peaks.. Representative peaks from FID and MS showed good correspondence in relative abundance.. The combined approach offers robust and orthogonal quantification.
What research method was used?
Comparative analytical study.
How strong is the evidence?
Evidence strength is rated Strong effect, based on a 2019 journal from bioRxiv (Cold Spring Harbor Laboratory).
What should I do differently in my next project?
When designing analytical workflows for complex biological samples, evaluate the potential benefits of coupling different detector types to a single chromatographic separation.
What are the limitations?
The study focused on human serum and a specific set of metabolites; generalizability to other sample types or broader metabolomic scopes may vary. The correspondence in relative abundance was assessed on representative peaks, not all.
Is there evidence that human serum affects design outcomes?
By using both GC-Orbitrap-MS and GC-FID detectors simultaneously, researchers could identify and quantify over 3.7 times more chemical signals (peaks) in human serum compared to using the mass spectrometer alone, with good agreement on the relative amounts of common signals. This dual-detector approach offers a more co Source: bioRxiv (Cold Spring Harbor Laboratory) (2019).
Where does this metabolomics research apply?
Clinical metabolomics research, analytical chemistry It sits within commercial production research on designdex.org.

Related research topics

human serum design research · evidence on human serum · does human serum improve design outcomes · metabolomics studies for designers · human serum and metabolomics findings · commercial production research evidence